Daptomycin
-
Subject Areas on Research
- A balancing act: microbe versus muscle.
- Acute eosinophilic pneumonia secondary to daptomycin: a report of three cases.
- An open-label, pragmatic, randomized controlled clinical trial to evaluate the comparative effectiveness of daptomycin versus vancomycin for the treatment of complicated skin and skin structure infection.
- CAMERA2 - combination antibiotic therapy for methicillin-resistant Staphylococcus aureus infection: study protocol for a randomised controlled trial.
- Ceftobiprole versus daptomycin in Staphylococcus aureus bacteremia: a novel protocol for a double-blind, Phase III trial.
- Clinical characteristics and outcomes of diabetic patients with Staphylococcus aureus bacteremia and endocarditis.
- Clinical management of Staphylococcus aureus bacteremia: a review.
- Combination Therapy for MRSA Bacteremia: To ß or Not to ß?
- Daptomycin compared to standard therapy for the treatment of native valve endocarditis.
- Daptomycin resistance in enterococci is associated with distinct alterations of cell membrane phospholipid content.
- Daptomycin use in infants: report of two cases with peak and trough drug concentrations.
- Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus.
- Daptomycin versus vancomycin plus gentamicin for treatment of bacteraemia and endocarditis due to Staphylococcus aureus: subset analysis of patients infected with methicillin-resistant isolates.
- Daptomycin-resistant Enterococcus faecalis diverts the antibiotic molecule from the division septum and remodels cell membrane phospholipids.
- Daptomycin: a rapidly bactericidal lipopeptide for the treatment of Gram-positive infections.
- Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A Randomized Clinical Trial.
- High-dose daptomycin therapy for left-sided infective endocarditis: a prospective study from the international collaboration on endocarditis.
- History of antibiotics: from fluoroquinolones to daptomycin (Part 2).
- Infective endocarditis caused by daptomycin-resistant Enterococcus faecalis: a case report.
- Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic.
- Microbiological and genotypic analysis of methicillin-resistant Staphylococcus aureus bacteremia.
- New treatments for methicillin-resistant Staphylococcus aureus.
- Optimizing therapy for methicillin-resistant Staphylococcus aureus bacteremia.
- Outcomes with daptomycin versus standard therapy for osteoarticular infections associated with Staphylococcus aureus bacteraemia.
- Pharmacokinetics and tolerability of single-dose daptomycin in young infants.
- Randomized Controlled Noninferiority Trial Comparing Daptomycin to Vancomycin for the Treatment of Complicated Skin and Skin Structure Infections in an Observation Unit.
- Reduced Chlorhexidine and Daptomycin Susceptibility in Vancomycin-Resistant Enterococcus faecium after Serial Chlorhexidine Exposure.
- Response to "Reassessing Claims of Non-inferiority of Daptomycin".
- Streptococcus mitis and S. oralis Lack a Requirement for CdsA, the Enzyme Required for Synthesis of Major Membrane Phospholipids in Bacteria.
-
Keywords of People
- Cohen-Wolkowiez, Michael, Kiser-Arena Distinguished Professor, Pediatrics, Infectious Diseases